ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1165

Pathogenicity of IL-17 Producing Cells in HLA-B27 Transgenic Rat Model of Spondyloarthritis

Marie Beaufrère1, Manon Jacoutot1, Amel Ait Ali Said1, Roula Said-Nahal2, Gina Cosentino3, Chiara Rizzo3, Maxime Breban4 and Simon Glatigny4, 1Paris Saclay University / INSERM 1173, Montigny-le-Bretonneux, France, 2Rheumatology Division - Ambroise Pare Hospital, APHP, Boulogne-Billancourt, France, 3INSERM 1173, Montigny-le-Bretonneux, France, 41INSERM U1173, UFR Simone Veil, Versailles-Saint Quentin / Paris-Saclay University, Montigny-le-Bretonneux, France

Meeting: ACR Convergence 2022

Keywords: chemokines, spondyloarthritis, TH17 Cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Spondyloarthritis Including PsA – Basic Science Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Spondylarthritis (SpA) is a group of chronic inflammatory disorders with osteoarticular and extraarticular symptoms, including colitis, highly associated with the human leukocyte antigen (HLA) class I allele HLA-B27. A strong association of SpA with HLA-B27 has been known for nearly 50 years but its pathogenic role remains largely unexplained. Transgenic rats expressing HLA-B27 and human b2-microglobulin (B27-rat) develop clinical manifestations resembling human SpA (rat SpA). Previous studies revealed that IL-17 and TNF-a are two major cytokines implicated in both SpA and rat SpA.

In this study, we aimed to determine which cell subset(s) produce key proinflammatory cytokines IL-17 and TNF-α during rat SpA and characterize their tissue distribution. Then, we evaluated if chemokine receptor can be used to isolate these subsets. Finally, we tested the pathogenicity of these proinflammatory cell subsets by transfer in athymic (nude) B27-rats.

Methods: Lymphoid cells were isolated from both inflamed tissues and lymphoid organs draining those tissues before and during rat SpA development and were characterized. Nontransgenic (NTG) littermates were used as control. Blood samples were used to translate B27-rat findings to HLA-B27+ SpA patients. Pathogenicity of purified CD4+ T cell subsets was assessed by transfer of 40,000 purified cell subsets in SpA-resistant athymic nude B27-rats.

Results: First, we showed that conventional T cells (CD4+ Foxp3–) were the main producers of both IL-17 and TNF-α and coproduced these cytokines during rat SpA. Importantly, those Th17 cells were already significantly expanded in the blood, bone marrow (BM), and colon of premorbid B27-rats. Then, we showed that CCR6 was a reliable marker to isolate all Th17 cells in rat. Similar findings were observed in SpA patients. Finally, transfer of HLA-B27+ purified Th17 (CCR6+) – but not Th1 – cells induced SpA symptoms (arthritis and colitis) in athymic B27-rats, providing the first direct evidence of a specific proarthritogenic role of Th17 cells in SpA.

Conclusion: Our study demonstrates that IL-17+TNFa+ Th17 cells are already expanded before disease development and are involved in SpA development. Further studies are required to determine the mechanism leading to the generation of these cells in colon and BM to identify new therapeutic targets.


Disclosures: M. Beaufrère, None; M. Jacoutot, None; A. Ait Ali Said, None; R. Said-Nahal, None; G. Cosentino, None; C. Rizzo, None; M. Breban, None; S. Glatigny, None.

To cite this abstract in AMA style:

Beaufrère M, Jacoutot M, Ait Ali Said A, Said-Nahal R, Cosentino G, Rizzo C, Breban M, Glatigny S. Pathogenicity of IL-17 Producing Cells in HLA-B27 Transgenic Rat Model of Spondyloarthritis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/pathogenicity-of-il-17-producing-cells-in-hla-b27-transgenic-rat-model-of-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pathogenicity-of-il-17-producing-cells-in-hla-b27-transgenic-rat-model-of-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology